RSS

Theresa L. O’Keefe, Ph.D.

Theresa O’Keefe, Ph.D., Chief Scientific Officer: Theresa has over 25 years in Immunology and Molecular Biology, Drug Discovery and Development as well as innovative water cleaning solutions. Following a Ph.D. at Tufts, and academic work at the MRC Lab Molecular Biology, Cambridge, UK, Dr. O’Keefe was recruited to biotech to drive the creation of Therapeutic Antibodies (LeukoSite, Millennium, Critical Therapeutics, Pfizer). Her work included safe therapeutics for acute and chronic diseases (i.e. RA, sepsis, Crohn's and psoriasis) as well as multiple types of cancer. Successes include many therapeutic drugs including Millennium’s Campath (for chronic lymphoid leukemia) and Vedolizumab (for Crohn’s). In addition, Dr. O’Keefe co-founded Waltham Technologies to develop waster cleaning to energy production processes. She is committed to improved human health both through innovative drugs and the creation of safer living environments. She is co-inventor of more than 25 patents and patent applications.

Chemotherapy drugs are life-saving drugs and can be given on an out-patient basis. This allows the patients to return home where their families can care for them. The most powerful chemotherapeutic drugs are genotoxic – they directly attack DNA. more

, Articles